# Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

> **NCT05800600** · PHASE2 · RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 34 (estimated)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Venofer

## Key facts

- **NCT ID:** NCT05800600
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-15
- **Primary completion:** 2026-02-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2025-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05800600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05800600, "Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05800600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*